
Human zzso zzso beta is the first therapeutic agent to convincingly reduce the multiple sclerosis zzso rate and zzso zzso To achieve this significant treatment advance over 15 years of preliminary work was necessary, encompassing over 15 controlled trials which employed each of the three human zzso Important insights into the zzso of multiple sclerosis zzso were gained, especially from the findings of the single zzso zzso This short history describes the unfolding of our current understanding of the place for zzso in the management of zzso The contribution of the patients who have participated is recognized and their courage zzso The final role for zzso treatment of zzso is zzso but future studies will be required to define the best zzso optimal dose, and route of administration and patient selection for long-term management of zzso 

